Holoprosencephaly, or HPE, is the most common congenital cerebral malformation in humans and the most severe of a group of pathologies related to a deficiency of the SHH signalling pathway (Sonic Hedgehog SHH-D). It is characterized by severe cerebral and craniofacial abnormalities. The regulation of SHH concentration is therefore crucial for correct craniofacial development. Despite the recent identification of about 20 genes, 70% of cases of EHPE and craniofacial midline abnormalities of genetic origin do not have a molecular diagnosis. It is therefore important to continue the search for new candidate genes to improve the understanding of brain and facial development and to improve genetic counseling for these families. The development of Next-Generation Sequencing (NGS) technologies opens up the possibility of studying the exome or even the genome in a single manipulation. The latter type of analysis is particularly well suited to the discovery of new genes and will therefore improve the care of patients and their families.
Study Type
OBSERVATIONAL
Enrollment
33
next-generation sequencing on preexisting samples
CHU Rennes
Rennes, France
Number of patients with an identified genetic abnormality
Number of patients with an identified genetic abnormality
Time frame: 6 months
Number of new genes identified
Number of new genes identified, and possible recurrence of variants in one or more new genes of interest.
Time frame: 6 months
Pathogenic variants
Percentage of pathogenic variants identified in genes of the SHH pathway
Time frame: 6 months
Modes of transmission of pathogenic variants
Percentage of variants identified according to the different modes of transmission (de novo, autosomal dominant, X-linked, autosomal recessive, oligogenism)
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.